ClinicalTrials.gg
RecruitingNCT07471243DRESS-XUpdated Aug 24, 2026

Dressing-related Experiences and Surgical Site Self-care in Hip and Knee Replacement: an Observational Cohort Study

An observational study in Total Hip Replacement and Total Knee Replacement, sponsored by Bournemouth University. Recruiting at 2 sites in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-24.

Sponsored by Bournemouth University · Observational

From the registry’s dates

  • Started Jul 2026; still recruiting 3 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this prospective observational cohort study is to investigate dressing-related experiences and surgical site self-care in patients who are undergoing a total hip or knee replacement. The main objectives of the study are:

  • To evaluate patient adherence to the ISWCAP self-care checklist after total hip or knee replacement within an ERAS pathway.
  • To explore patient-reported outcomes related to the performance and comfort of advanced dressings.
  • To assess the perceived adequacy and usefulness of post-discharge wound care education.
  • To identify the incidence and types of wound-related complications in the 12 weeks following surgery.

Participants will give informed consent before surgery and will start the study once the dressing has been applied following surgery. There will be follow up study visits at discharge, 7 days, 12 days, 6 weeks and 12 weeks post-surgery. Data relating to vital signs, medical history, surgery and medication will be taken from routine data.

02

Conditions studied

  • Total Hip Replacement
  • Total Knee Replacement

Browse trials for

Keywords

  • Hip arthroplasty
  • Hip replacement
  • Knee arthroplasty
  • Knee replacement
  • Musculoskeletal
  • Enhanced recovery after surgery
  • ERAS
  • Surgical wound
03

In context

Surgical Wound

315 studies on the registry are indexed under Surgical Wound; 57 are open to participants now.

This study's planned enrollment of 100 is above the median of 72 across 51 observational studies indexed under Surgical Wound.

Browse Surgical Wound studies →

Lead sponsor

Bournemouth University is the lead sponsor of 52 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients undergoing primary total hip or knee replacement at the Nuffield Health Hospital

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults (18+) undergoing primary total hip or knee replacement
  • Enrolled in an ERAS protocol
  • Willing and able to provide

Exclusion criteria

Exclusion Criteria:

  • Requiring revision replacement
  • Unable to provide (cognitive disorder such as dementia, psychiatric illness)
  • Unable to understand written English
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Interventions

  • OtherWound Dressing Material

    The study will investigate any wound dressing applied as part of routine care. Advanced wound dressings are highly absorbent, flexible and comfortable for surgical wounds, and offer up to 14 days wear time. The adhesive moulds to the skin without sticking to the wound, thus protecting the skin and wound from damage. They support patient mobilisation by being comfortable, and thereby minimising painful skin damage such as blisters.

06

What researchers measure

Primary outcomes

  1. The proportion of participants responding "yes" to each item of the ISWCAP checklist at 6-weeks post-surgery

    Time frame: 6-weeks post surgery

Secondary outcomes

  1. Incidence and types of wound complications such as infection, dehiscence (as measured by the Sandy Grading System for surgical wound dehiscence classification), and blistering in the 12-weeks following surgery

    Time frame: From surgery until the 12-week follow-up appointment

  2. Bluebelle Wound Healing Questionnaire, completed at Visits 5 (12-days post-surgery) and 6 (6-weeks post-surgery)

    Time frame: 12-days post-surgery and 6-weeks post-surgery

  3. Dressing Comfort and Usability Survey completed at Visits 4 (7-days post-surgery) and 5 (12-days post-surgery)

    Time frame: 7- and 12-days post-surgery

07

Study locations

1 of 2 sites recruiting
  • Nuffield Health Hospital Bournemouth
    Bournemouth, Dorset BH1 1RW, United Kingdom
    Recruiting
    • Robert Middleton · Contact
    • Robert Middleton · Principal investigator
  • Bournemouth University
    Bournemouth, Dorset BH8 8EB, United Kingdom
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Aug 2027, 13 months after the start.

Of 31 observational studies under Surgical Wound, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 48. This study's planned 13 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 10, 2026
First posted
Mar 13, 2026
StartActual
Jul 23, 2026
Primary completionEst.
Aug 31, 2027
CompletionEst.
Aug 31, 2027
Last update
Aug 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07471243
Lead sponsor
Bournemouth University
Collaborators
Nuffield Health Bournemouth
Responsible party
Tom Wainwright (Professor of Orthopaedics, Bournemouth University) — Principal investigator
First posted
Mar 13, 2026
Start date
Jul 23, 2026
Primary completion
Aug 31, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
Aug 24, 2026

Study contacts

Tikki Immins
Contact
timmins@bournemouth.ac.uk
+441202 962727
Chloe Bascombe
Contact
cbascombe@bournemouth.ac.uk
+441202 961945
Thomas Wainwright
principal investigator · Bournemouth University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion